Jupai Holdings Limited (JP) |
| 0.38 0 (0%) 04-24 15:47 |
| Open: | 0.4 |
| High: | 0.4 |
| Low: | 0.3773 |
| Volume: | 78,240 |
| Market Cap: | 0(M) |
| PE Ratio: | -0.32 |
| Exchange: | New York Stock Exchange |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 1.79 |
| 52w Low: | 0.00111 |
Jupai Holdings Limited, along with its various subsidiaries, delivers comprehensive wealth management solutions and expert financial advisory services, primarily targeting affluent individuals throughout China. The company's diverse array of offerings spans traditional investment categories such as fixed income instruments, private equity and venture capital funds, and public market securities. Furthermore, it provides access to specialized products including international insurance policies and alternative investments denominated in foreign currencies. Beyond these, Jupai also offers robust asset management services, encompassing the oversight of real estate funds, related investment vehicles, and various other fund products. Its capabilities extend to include direct fund management, complemented by a suite of advisory and administrative support services. By the end of 2021, the firm had established a significant operational footprint, managing 22 client-facing branches located across 22 distinct cities in both Mainland China and Hong Kong. Headquartered in Shanghai, China, Jupai Holdings Limited commenced operations in 2010, having initially been known as Jupai Investment Group before officially adopting its current name in December 2014.
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |